<DOC>
	<DOCNO>NCT02777463</DOCNO>
	<brief_summary>To investigate correlation pretreatment ADC value diffusion MRI pathologic response patient borderline resectable pancreatic carcinoma undergo neoadjuvant therapy .</brief_summary>
	<brief_title>The Prediction Using Diffusion MRI Response Evaluation BRPC NAT .</brief_title>
	<detailed_description>Aim : The prediction use diffusion-weighted MRI response evaluation borderline resectable pancreatic cancer . Study design : Single institution . Single arm . Prospective Phase II Study . Number case : 28 Patients : The prediction use dMRI response evaluation borderline resectable pancreatic carcinoma ( BRPC ) neoadjuvant therapy . Disease : Pancreatic carcinoma Method : To investigate correlation pretreatment ADC value diffusion MRI pathologic response patient borderline resectable pancreatic carcinoma undergo neoadjuvant therapy . The correlation pretreatment ADC value diffusion MRI pathologic response evaluate Evans grade patient borderline resectable pancreatic carcinoma ( BRPC ) undergo neoadjuvant therapy . 1 . The correlation pretreatment ADC value abutment site BRPC rate tumor cell destruction . 2 . The correlation posttreatment ADC value abutment site BRPC rate tumor cell destruction . 3 . The correlation ratio posttreatment/pretreatment ADC value abutment site BRPC rate tumor cell destruction . 4 . The correlation pretreatment ADC value BRPC tumor large diameter rate tumor cell destruction . 5 . The correlation ratio posttreatment/pretreatment ADC value BRPC tumor large diameter rate tumor cell destruction . 6 . ADC Cut-off value predict 50 % le 10 % tumor cell destruction rate . 7 . The correlation ratio posttreatment/pretreatment ADC value BRPC tumor large diameter ratio posttreatment/pretreatment SUV max . 8 . ADC Cut-off value SUV max cut-off value predict survival time surgery 2 year less 2 year . 9 . The comparison accuracy prediction pathological diagnosis abutment site ratio posttreatment/pretreatment ADC value CT scan . 10 . Three correlation high ADC value/low ADC value/the ratio posttreatment/pretreatment ADC value survival time surgery . 11 . Three correlation high ADC value/low ADC value/the ratio posttreatment/pretreatment ADC value decrease rate CA19-9 value . 12 . The correlation tumor 's limb sign diffusion MRI rate tumor cell destruction 10 % .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<criteria>The patient borderline resectable pancreatic cancer expexted undergo neoadjuvant therapy subsequent radical surgery .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>